![Anthony Ian Walker](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anthony Ian Walker
Founder at Alacrita LLP
Anthony Ian Walker active positions
Companies | Position | Start | End |
---|---|---|---|
Alacrita LLP
![]() Alacrita LLP Miscellaneous Commercial ServicesCommercial Services Alacrita LLP is an expertise-based consulting firm that offers consulting support on a range of R&D and business issues to biotech and pharma companies, academic institutions, and healthcare investors. Alacrita was founded in 2009 by Anthony Ian Walker and is based in London, UK. The British company conducts more than 250 successful client assignments every year and has a broad network of specialized consultants who can be engaged as necessary when additional, specialized expertise is required. Its core team leverages a consulting network of 250+ functional specialists, all with at least 20 years of pharmaceutical industry experience, allowing it to offer a versatile combination of depth and breadth in expertise that is unrivaled in the industry and that can be precisely tailored to the needs of each client. | Founder | 30/04/2009 | - |
Private Equity Investor | 30/04/2009 | - |
Career history of Anthony Ian Walker
Former positions of Anthony Ian Walker
Companies | Position | Start | End |
---|---|---|---|
SBI JI Innovation Advisory Ltd.
![]() SBI JI Innovation Advisory Ltd. Investment ManagersFinance SBI JI Innovation Advisory Ltd (SBI JI Innovation Advisor) is a venture capital firm founded in 2017. The firm is headquartered in Tel Aviv-Yafo, Israel. | Private Equity Investor | 31/12/2019 | 31/01/2024 |
Leucid Bio Ltd.
![]() Leucid Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Leucid Bio Ltd. is a clinical-stage biotechnology company based in London, UK. The British company develops novel, lateral car cell therapies for the treatment of refractory cancers, with a focus on developing next-generation cell therapies for the benefit of individuals with hard-to-treat solid tumors. The company's operations are based at Guys Hospital, enabling them to maintain a patient-centric focus. Leucid's goal is to develop CAR-T therapies with more durable responses, improving treatment outcomes and saving the lives of patients with refractory cancers. Leucid was established to translate 20 years of Kings College research in the CAR-T field and is led by a highly experienced management team, including scientific founder John Maher. Filippo Joseph Petti has been the CEO of the company since 2023. | Chief Executive Officer | 30/09/2016 | 30/09/2018 |
Founder | 30/09/2016 | 30/09/2018 | |
PROTEOME SCIENCES PLC | Director/Board Member | 26/12/2010 | 02/03/2014 |
PROTEOME SCIENCES PLC | Director/Board Member | 30/11/2010 | 28/02/2014 |
Wilkerson Group
![]() Wilkerson Group Medical/Nursing ServicesHealth Services Part of International Business Machines Corp., Wilkerson Group is a consulting company that provides services to the pharmaceutical and medical products industry. The company is based in New York, NY. The company was founded by Kenneth D. Noonan. The CEO is Neil MacAllister. Wilkerson Group was acquired by International Business Machines Corp. on April 01, 1996. | Corporate Officer/Principal | - | 31/12/1996 |
Arthur D. Little, Inc.
![]() Arthur D. Little, Inc. Miscellaneous Commercial ServicesCommercial Services Arthur D. Little, Inc. engages in the provision of management consulting services. It specializes in strategy and organization, operations management, technology and innovation management, corporate finance, and global carbon advisory serving corporations and organizations worldwide. The firm serves the automotive, healthcare, information, chemicals, consumer goods, retail, manufacturing, and transportation industries. The company was founded by Arthur Dehon Little and Roger Griffin in October 1886 and is headquartered in Boston, MA. | Consultant / Advisor | 30/11/1985 | 30/06/1994 |
Arthur D. Little, Inc.
![]() Arthur D. Little, Inc. Miscellaneous Commercial ServicesCommercial Services Arthur D. Little, Inc. engages in the provision of management consulting services. It specializes in strategy and organization, operations management, technology and innovation management, corporate finance, and global carbon advisory serving corporations and organizations worldwide. The firm serves the automotive, healthcare, information, chemicals, consumer goods, retail, manufacturing, and transportation industries. The company was founded by Arthur Dehon Little and Roger Griffin in October 1886 and is headquartered in Boston, MA. | Director/Board Member | - | - |
Onyvax Ltd.
![]() Onyvax Ltd. Miscellaneous Commercial ServicesCommercial Services Onyvax Ltd. developed cancer remedy therapies. The company was founded in 1995 and was headquartered in Bradford, the United Kingdom. | Founder | 09/11/2009 | - |
President | 31/12/1996 | - |
Training of Anthony Ian Walker
University of Cambridge | Undergraduate Degree |
Statistics
International
United Kingdom | 6 |
United States | 3 |
Israel | 2 |
Operational
Founder | 3 |
Director/Board Member | 3 |
Private Equity Investor | 2 |
Sectoral
Commercial Services | 5 |
Health Services | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
PROTEOME SCIENCES PLC | Health Technology |
Private companies | 6 |
---|---|
Onyvax Ltd.
![]() Onyvax Ltd. Miscellaneous Commercial ServicesCommercial Services Onyvax Ltd. developed cancer remedy therapies. The company was founded in 1995 and was headquartered in Bradford, the United Kingdom. | Commercial Services |
Arthur D. Little, Inc.
![]() Arthur D. Little, Inc. Miscellaneous Commercial ServicesCommercial Services Arthur D. Little, Inc. engages in the provision of management consulting services. It specializes in strategy and organization, operations management, technology and innovation management, corporate finance, and global carbon advisory serving corporations and organizations worldwide. The firm serves the automotive, healthcare, information, chemicals, consumer goods, retail, manufacturing, and transportation industries. The company was founded by Arthur Dehon Little and Roger Griffin in October 1886 and is headquartered in Boston, MA. | Commercial Services |
Wilkerson Group
![]() Wilkerson Group Medical/Nursing ServicesHealth Services Part of International Business Machines Corp., Wilkerson Group is a consulting company that provides services to the pharmaceutical and medical products industry. The company is based in New York, NY. The company was founded by Kenneth D. Noonan. The CEO is Neil MacAllister. Wilkerson Group was acquired by International Business Machines Corp. on April 01, 1996. | Health Services |
Alacrita LLP
![]() Alacrita LLP Miscellaneous Commercial ServicesCommercial Services Alacrita LLP is an expertise-based consulting firm that offers consulting support on a range of R&D and business issues to biotech and pharma companies, academic institutions, and healthcare investors. Alacrita was founded in 2009 by Anthony Ian Walker and is based in London, UK. The British company conducts more than 250 successful client assignments every year and has a broad network of specialized consultants who can be engaged as necessary when additional, specialized expertise is required. Its core team leverages a consulting network of 250+ functional specialists, all with at least 20 years of pharmaceutical industry experience, allowing it to offer a versatile combination of depth and breadth in expertise that is unrivaled in the industry and that can be precisely tailored to the needs of each client. | Commercial Services |
SBI JI Innovation Advisory Ltd.
![]() SBI JI Innovation Advisory Ltd. Investment ManagersFinance SBI JI Innovation Advisory Ltd (SBI JI Innovation Advisor) is a venture capital firm founded in 2017. The firm is headquartered in Tel Aviv-Yafo, Israel. | Finance |
Leucid Bio Ltd.
![]() Leucid Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Leucid Bio Ltd. is a clinical-stage biotechnology company based in London, UK. The British company develops novel, lateral car cell therapies for the treatment of refractory cancers, with a focus on developing next-generation cell therapies for the benefit of individuals with hard-to-treat solid tumors. The company's operations are based at Guys Hospital, enabling them to maintain a patient-centric focus. Leucid's goal is to develop CAR-T therapies with more durable responses, improving treatment outcomes and saving the lives of patients with refractory cancers. Leucid was established to translate 20 years of Kings College research in the CAR-T field and is led by a highly experienced management team, including scientific founder John Maher. Filippo Joseph Petti has been the CEO of the company since 2023. | Commercial Services |
- Stock Market
- Insiders
- Anthony Ian Walker
- Experience